Edmonton, Alberta, Canada, March 11, 2021.
Pacylex Pharmaceuticals, an oncology company unlocking a new approach to cancer therapy, announced the receipt of a No Objection Letter from Health Canada on March 8, 2021, opening the way for a planned Phase 1 Trial of PCLX-001 in r...